Mehmet MADEN, CENK ER, Kürşat KAV, ÖZGÜR ÖZDEMİR

İngiliz pointer ırkı bir köpekte Demodex canis kökenli atipik dermatitis olgusunun başarılı sağaltımı

Bu olgu sunumunda, 5 yaşlı İngiliz Pointer ırkı bir köpekte Demodex canis kökenli atipik dermatitisin teşhisi ve tedavisi değerlendirildi. Klinik, laboratuvar, bakteriyolojik, parazitolojik ve histopatolojik muayeneler ışığında, deri kazıntısı ve deri biyopsisi örneklerinden Demodex canis, β-hemolitik Staphylococcus aureus ve Microsporum canis izole ve identifiye edilen bu olgu, atipik dermatitis olarak tanımlandı. Banyo uygulaması (ketokonazol ve benzoxyl peroxide şampuan, haftada 2 kez), ivermektin (0.6 mg/kg, SC, 3 gün ara ile, 4 ay), sefaperazon-sulbaktam kombinasyonu (22 mg/kg, 10 gün), cefquinom (2 mg/kg, İM, 3.5 ay) ve ketokonazol (10 mg/kg, oral, 4 ay) ile dört ay boyunca tedavi edildi. Sonuç olarak, Demodex canis kökenli atipik dermatitis olgularında tedavi süresinin uzun tutulması gerektiği ve 3 günlük aralıklarla yapılan ivermektin tedavisinin başarılı olduğu ve herhangi bir komplikasyona neden olmadığı değerlendirildi.

Anahtar Kelimeler:

Staphylococcus aureus, Demodex canis, Microsporum canis, klinik görünüm, deri yangısı, teşhis, köpek, ektoparasitik, histopatoloji, ketakonazol, tedavi

Successful treatment of atypical dermatitis case caused by Demodex canis in an english pointer

In this case, the diagnosis and treatment of atypical dermatitis caused by Demodex canis was evaluated in a-5 year old English pointer. The disease defined as atypical dermatitis due to clinical, laboratory, bacteriological, parasitological and histopatological results. Demodex canis, β-hemolytic Staphylococcus aureus and Microsporum canis were isolated and identified on the skin scrapings, biopsy specimens and swab. The dog was treated for 4 months, given bath of ketoconazole and benzoyl peroxide shampoo, twice in a week, ivermectin 0.6 mg/kg, SC, three days interval, cefaperazone-sulbactam (22 mg/kg, IM) daily for only 10 days and followed by cefquinom (2 mg/kg IM) daily for the rest of the treatment period of 3.5 months, and ketaconazole (10 mg/kg, PO, 4 months) daily. As a result, atypical dermatitis caused by Demodex canis should be treated for longer duration with no complications and with successful outcome at 3 days interval.

Keywords:

Staphylococcus aureus, Demodex canis, Microsporum canis, clinical aspects, dermatitis, diagnosis, dogs, ectoparasiticides, histopathology, ketoconazole, therapy,

PDF

___

1. Scott DW, Miller WH, Griffin CE: Parasitic skin disease. In, Muller&Kirk’s Small Animal Dermatology. 6th ed., pp. 423 -516, WB Saunders, Philadelphia. 2001.
2. Gortel K: Update on Canine Demodicosis. Vet Clin North Am: Small Anim Pract, 36 (1): 229-241, 2006.
3. Mueller RS: Treatment protocols for demodicosis: An evidence based review. Vet Dermatol, 15 (2): 75-89, 2004.
4. Tater KC, Patterson AC: Canine and feline demodicosis. Vet Med, 444-461, 2008.
5. Desch CE, Hillier A: Demodex injai: A new species of hair follicle mite (Acari:Demodecidae) from the domestic dog (Canidae). J Med Entomol, 40 (2): 146-149, 2003.
6. Tamura Y, Kawamura Y, Inoue I, Ishino S: Scanning electron microscopy description of a new species of Demodex canis spp. Vet Dermatology, 12 (5):275-278, 2001.
7. Horne KL: Canine Demodicosis. Veterinary Technician, MARCH 2010. (https://s3.amazonaws.com/assets.prod.vetlearn.com/mmah/ce/551d0 3e8414491b97d7edba24d29aa/fileVT0310_pr_horneCE.pdf, Accessed: February 2011).
8. Singh SK, Kumar M, Jadhav RK, Saxena SK: An update on therapeutic management of canine demodicosis. Vet World, 4 (1): 41-44, 2011.
9. Macdonald H, Gledhill A: Potential impact of ABC±(p-glycoprotein) polymorphisims on avermectin toxicity in humans. Arch Toxicol, 81 (8): 553-563, 2007.
10. Dimri U, Singh SK, Sharma MC, Kumar P, Waila T, Kumar S, Ranjan R, Kumar N: Efficacy of doramectin against canine demodicosis. Indian Vet J, 86 (11): 1127-1128, 2009.
11. Avşaroğulları L, İkizceli İ, Sungur M, Sözüer E, Akdur O, Yücei M: Acute amitraz poisoning in adults: Clinical features, laboratory findings and management. Clin toxicol, 44 (1): 19-23, 2006.
12. Seward RL: Reactions in dogs given ivermektin. JAVMA, 182, 493, 1983. 13. Hopper K, Aldrich J, Haskins SC: Ivermectin toxicity in 17 collies. J Vet Intern Med, 16 (1): 89-94, 2002.
14. Sherman JG: Understanding the impact of P-glycoprotein mutation on canine health. Vet J, 190, 13-14, 2011.
15. Clarke DL, Lee JA, Murphy LA, Reineke EL: Use of intravenous lipid emulsion to treat ivermektin toxicosis in a Border Collie. JAVMA, 239 (10): 1328-1333, 2011.
16. Holm BR: Efficacy of milbemycin oxime in the treatment of canine generalized demodicosis: A retrospective study of 99 dogs (1995-2000). Vet Dermatol, 14 (4): 189-195, 2003.
17. Mueller RS, Hastie K, Bettenay SV: Daily oral ivermectin for treatment of generalised demodicosis in 23 dogs. Austr Vet Pract, 29, 132-137, 1999.
18. Mueller RS, Hastie K, Bettenay SV: Daily oral ivermectin for the treatment of generalised demodicosis in 23 dogs. Australian Veterinary Practitioner, 29, 132-136, 1999.
19. Fondati A: Efficacy of daily oral ivermectin in the treatment of 10 cases of generalized demodicosis in adult dogs. Veterinary Dermatology, 7, 99-104,1996.
20. Medleau L, Ristic Z, McElveen DR: Daily ivermectin for treatment of generalized demodicosis in dogs. Veterinary Dermatology, 7, 209-212, 1996.
21. Ristic Z, Medleau L, Paradis, M, White-Weithers NE: Ivermectin for treatment of generalized demodicosis in dogs. JAVMA, 207, 1308-1310, 1995.
22. Mueller RS: Ivermectin for treatment of generalized demodicosis in dogs. Veterinary Dermatology, 15, 75-89, 2004.
23. Reinemeyer CR, Courtney CH: Chemotherapy of Parasitic Diseases-Antinematodal Drugs. In, Richard Adams H (Ed): Veterinary Pharmacology and Therapeutics. pp. 947-979, Iowa State University Press, Iowa, 2001.
24. Kahn MC: The Merck Veterinary Manuel 9th ed., Whitehouse Station, NJ, USA 2011.
25. Watson TDG: Diet and skin dissease in dogs and cats. J Nutr, 128, 2783- 2789, 1998.